• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PCV10 可在巴布亚新几内亚儿童中引起蛋白 D IgG 应答,但在生命的头两年对 NTHi 携带没有影响。

PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.

机构信息

Division of Paediatrics, University of Western Australia, Western Australia, Australia; Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Western Australia, Australia.

Papua New Guinea Institute of Medical Research, Goroka, Eastern Highlands Province, Papua New Guinea.

出版信息

Vaccine. 2021 Jun 11;39(26):3486-3492. doi: 10.1016/j.vaccine.2021.05.022. Epub 2021 May 21.

DOI:10.1016/j.vaccine.2021.05.022
PMID:34024658
Abstract

BACKGROUND

Nasopharyngeal colonisation with nontypeable Haemophilus influenzae (NTHi) is associated with development of infections including pneumonia and otitis media. The 10-valent pneumococcal conjugate vaccine (PCV10) uses NTHi Protein D (PD) as a carrier. Papua New Guinean children have exceptionally early and dense NTHi carriage, and high rates of NTHi-associated disease. Vaccination with PCV10 could potentially reduce NTHi carriage and disease in this population by inducing a NTHi PD immune response.

METHODS

Serum and nasopharyngeal swabs were collected from 101 Papua New Guinean children at 1, 4, 9, 10, 23 and 24 months of age. Children received PCV10 (n = 55) or PCV13 (not containing NTHi PD) (n = 46) at 1, 2 and 3 months of age. NTHi carriage density was measured in swabs by qPCR. Serum PD-IgG levels were measured by bead-based immunoassay.

RESULTS

Papua New Guinean children did naturally develop PD-IgG antibodies whose levels were increased at 4 months of age with PCV10 vaccination at 1-2-3 months. Despite this, most children were colonised with NTHi by 4 months of age (~95%) regardless of being vaccinated with PCV10 or PCV13, and PCV10 had no impact on NTHi carriage density.

CONCLUSION

Early vaccination of infants with PCV10 elicited a robust PD antibody response but this had no impact on NTHi carriage.

TRIAL REGISTRATION

ClinicalTrials.gov CTN NCT01619462.

摘要

背景

鼻咽部定植的流感嗜血杆菌(NTHi)与肺炎和中耳炎等感染的发展有关。10 价肺炎球菌结合疫苗(PCV10)使用 NTHi 蛋白 D(PD)作为载体。巴布亚新几内亚的儿童鼻咽部定植 NTHi 的时间异常早且密集,NTHi 相关疾病的发生率也很高。接种 PCV10 可能通过诱导 NTHi PD 免疫应答,减少该人群中 NTHi 的定植和疾病。

方法

101 名巴布亚新几内亚儿童在 1、4、9、10、23 和 24 个月时采集血清和鼻咽拭子。儿童在 1、2 和 3 个月时接受 PCV10(n=55)或不包含 NTHi PD 的 PCV13(n=46)接种。qPCR 检测拭子中 NTHi 的定植密度。通过基于珠子的免疫测定法测量血清 PD-IgG 水平。

结果

巴布亚新几内亚儿童自然产生 PD-IgG 抗体,其水平在 4 个月时接种 PCV10 后增加。尽管如此,大多数儿童在 4 个月时已被 NTHi 定植(~95%),无论接种 PCV10 还是 PCV13,PCV10 对 NTHi 的定植密度均无影响。

结论

婴儿早期接种 PCV10 可引起强烈的 PD 抗体反应,但对 NTHi 的定植无影响。

试验注册

ClinicalTrials.gov CTN NCT01619462。

相似文献

1
PCV10 elicits Protein D IgG responses in Papua New Guinean children but has no impact on NTHi carriage in the first two years of life.PCV10 可在巴布亚新几内亚儿童中引起蛋白 D IgG 应答,但在生命的头两年对 NTHi 携带没有影响。
Vaccine. 2021 Jun 11;39(26):3486-3492. doi: 10.1016/j.vaccine.2021.05.022. Epub 2021 May 21.
2
Safety and Immunogenicity of Pneumococcal Conjugate Vaccines in a High-risk Population: A Randomized Controlled Trial of 10-Valent and 13-Valent Pneumococcal Conjugate Vaccine in Papua New Guinean Infants.高危人群中肺炎球菌结合疫苗的安全性和免疫原性:10 价和 13 价肺炎球菌结合疫苗在巴布亚新几内亚婴儿中的随机对照试验。
Clin Infect Dis. 2019 Apr 24;68(9):1472-1481. doi: 10.1093/cid/ciy743.
3
Differences in Pneumococcal and Natural Antibody Development in Papua New Guinean Children in the First Year of Life.巴布亚新几内亚儿童生命第一年中肺炎球菌和天然抗体发育的差异。
Front Immunol. 2021 Aug 10;12:725244. doi: 10.3389/fimmu.2021.725244. eCollection 2021.
4
Pneumococcal carriage, serotype distribution, and antimicrobial susceptibility in Papua New Guinean children vaccinated with PCV10 or PCV13 in a head-to-head trial. Papua New Guinean 儿童在头对头试验中接种 PCV10 或 PCV13 后的肺炎球菌携带情况、血清型分布和抗生素敏感性。
Vaccine. 2023 Aug 23;41(37):5392-5399. doi: 10.1016/j.vaccine.2023.07.026. Epub 2023 Jul 20.
5
Effect of 10-valent pneumococcal conjugate vaccine on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae among children in São Paulo, Brazil.10价肺炎球菌结合疫苗对巴西圣保罗儿童鼻咽部肺炎链球菌和流感嗜血杆菌携带情况的影响。
Vaccine. 2016 Nov 4;34(46):5604-5611. doi: 10.1016/j.vaccine.2016.09.027. Epub 2016 Sep 28.
6
PCV7- and PCV10-Vaccinated Otitis-Prone Children in New Zealand Have Similar Pneumococcal and Densities in Their Nasopharynx and Middle Ear.新西兰接种7价肺炎球菌结合疫苗(PCV7)和10价肺炎球菌结合疫苗(PCV10)的易患中耳炎儿童的鼻咽部和中耳中的肺炎球菌及密度相似。
Vaccines (Basel). 2019 Jan 31;7(1):14. doi: 10.3390/vaccines7010014.
7
Nasopharyngeal carriage of otitis media pathogens in infants receiving 10-valent non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10), 13-valent pneumococcal conjugate vaccine (PCV13) or a mixed primary schedule of both vaccines: A randomised controlled trial.婴幼儿接种 10 价无荚膜流感嗜血杆菌蛋白 D 结合疫苗(PHiD-CV10)、13 价肺炎球菌结合疫苗(PCV13)或两者混合基础免疫程序后鼻咽部携带中耳炎病原菌的情况:一项随机对照试验。
Vaccine. 2021 Apr 15;39(16):2264-2273. doi: 10.1016/j.vaccine.2021.03.032. Epub 2021 Mar 23.
8
Lack of effectiveness of 13-valent pneumococcal conjugate vaccination against pneumococcal carriage density in Papua New Guinean infants.13 价肺炎球菌结合疫苗对巴布亚新几内亚婴儿肺炎球菌携带密度的有效性缺乏。
Vaccine. 2021 Sep 7;39(38):5401-5409. doi: 10.1016/j.vaccine.2021.07.085. Epub 2021 Aug 9.
9
Effectiveness of the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D-Conjugated Vaccine (PHiD-CV) Against Carriage and Acute Otitis Media-A Double-Blind Randomized Clinical Trial in Finland.10 价肺炎球菌/流感嗜血杆菌蛋白 D 结合疫苗(PHiD-CV)在芬兰预防携带和急性中耳炎的有效性:一项双盲随机临床试验。
J Pediatric Infect Dis Soc. 2016 Sep;5(3):237-248. doi: 10.1093/jpids/piw010. Epub 2016 Apr 28.
10
Effect of a 2+1 schedule of ten-valent versus 13-valent pneumococcal conjugate vaccine on pneumococcal carriage: Results from a randomised controlled trial in Vietnam.十价与十三价肺炎球菌结合疫苗2+1接种程序对肺炎球菌携带情况的影响:越南一项随机对照试验的结果
Vaccine. 2021 Apr 15;39(16):2303-2310. doi: 10.1016/j.vaccine.2021.02.043. Epub 2021 Mar 19.

引用本文的文献

1
An infant mouse model of influenza-driven nontypeable colonization and acute otitis media suitable for preclinical testing of novel therapies.适合新型疗法临床前测试的流感驱动非分型定植和急性中耳炎的婴儿小鼠模型。
Infect Immun. 2024 May 7;92(5):e0045323. doi: 10.1128/iai.00453-23. Epub 2024 Apr 11.
2
Differences in Pneumococcal and Natural Antibody Development in Papua New Guinean Children in the First Year of Life.巴布亚新几内亚儿童生命第一年中肺炎球菌和天然抗体发育的差异。
Front Immunol. 2021 Aug 10;12:725244. doi: 10.3389/fimmu.2021.725244. eCollection 2021.